Loading organizations...
§ Venture Capital · London, United Kingdom
Venture capital firm investing in alternative protein technologies to disrupt the food system, backing plant-based and cultivated meat.
Key people at CPT Capital.
CPT Capital is a London-based venture capital firm that invests in alternative protein technologies designed to replace animals in the global food supply chain. Operating exclusively as the dedicated venture capital arm of a leading private family office, the firm provides targeted financing to early-stage companies developing plant-based proteins, biomass fermentation, recombinant proteins, and cultivated meat products. The organization supports its portfolio companies through multiple stages of corporate growth, providing strategic capital from initial pre-seed funding rounds through to eventual commercial scale, acquisitions, or initial public offerings. Its active investment portfolio of more than 50 companies features several prominent entities operating within the sustainable food technology and materials sector, including recognizable industry leaders such as Beyond Meat, Impossible Foods, Upside Foods, and Perfect Day. CPT Capital was officially founded in 2013 by Jeremy Coller.
Key people at CPT Capital.
CPT Capital is the venture capital arm of a prominent private family office focused on investing in the alternative protein sector. Its mission is to drive a food and materials technology revolution by replacing animals in the supply chain. The firm partners with visionary companies that use cutting-edge technologies such as plant-based proteins, biomass fermentation, recombinant proteins, and cultivated meat to disrupt the traditional food system. CPT Capital invests across early to growth stages, from pre-Seed to IPO or sale, backing bold startups shaping the future of sustainable food and materials[1][3][4].
Founded as the venture arm of a leading private family office, CPT Capital has evolved into a dedicated investor with deep expertise in alternative proteins. While the exact founding year is not specified, the firm has established itself as a long-standing player in this niche. Its focus has expanded alongside the growth of the alternative protein ecosystem, supporting companies pioneering innovations like Impossible Foods and Beyond Meat, as well as cultivated meat producers such as Upside Foods[1][3][4].
CPT Capital rides the global trend toward sustainable food systems driven by environmental, ethical, and health concerns. The timing is critical as consumer demand for alternative proteins grows alongside advances in biotechnology and food science. Market forces such as climate change, resource scarcity, and regulatory shifts favor innovations that reduce reliance on animal agriculture. CPT Capital influences the ecosystem by funding pioneering startups that accelerate the transition to a more sustainable and ethical food supply chain[1][3][4].
Looking ahead, CPT Capital is poised to deepen its impact as alternative proteins move from niche to mainstream markets. Trends like precision fermentation, cellular agriculture, and biomimicry will shape its investment focus. The firm’s influence will likely expand through continued support of breakthrough technologies and scaling companies that redefine food production. As global pressures on food systems intensify, CPT Capital’s role as a catalyst for sustainable innovation will become increasingly vital[1][3].
CPT Capital has more than 26 tracked investments across 21 companies. The latest tracked deal is $4.0M Seed in Asterix Foods in October 2025.
